Saypha Volume Plus Lidocaine

Saypha Volume Plus Lidocaine is a viscoelastic implant from Croma-Pharma in Austria, designed to correct moderate to severe midface volume deficit. Intended for qualified practitioners, it must be administered by deep subcutaneous and/or supraperiosteal injection. Its cross-linked hyaluronic acid, obtained from Streptococcus equi bacteria, is supplemented with lidocaine hydrochloride and phosphate buffered, providing 2.5% sodium hyaluronate (equivalent to 25 mg/mL), lidocaine HCl 0.3% and BDDE at 2 ppm or less, for professional use. Each box contains one pre-filled 1.0 mL syringe with two 27G 1/2 inch needles, three patient record labels and an international implant card.

• Corrects moderate to severe midface volume deficit
• Cross-linked sodium hyaluronate at 25 mg/mL, the highest concentration in the Saypha range
• Of non-animal origin, obtained from Streptococcus equi bacteria
• Contains lidocaine hydrochloride 0.3%, which reduces pain and discomfort during injection
• BDDE cross-linking agent present at 2 ppm or less
• Steam sterilised in the syringe, which serves as the sterile barrier
• Supplied with two 27G 1/2 inch needles, three patient record labels and an international implant card
• Manufactured by Croma-Pharma in Austria

适应症与专业用途

主要适应症

• Moderate to severe midface volume deficit

专业用途

Saypha Volume Plus Lidocaine is intended for an appropriately trained healthcare professional who is qualified or accredited in accordance with national law, and is not intended to be used by lay persons. It is administered by deep subcutaneous and/or supraperiosteal injection, which demands advanced anatomical knowledge of the midface. For healthy adults the maximum total dose of lidocaine hydrochloride should not exceed 300 mg, or 4.5 mg per kg body weight, whichever is less, per session; where other forms of lidocaine are used concurrently, whether topical or injected, the maximum total dose must be considered, and the concomitant use of other local anaesthetics or agents structurally related to amide-type anaesthetics should also be taken into account since systemic toxicity may be additive.

治疗部位

• Midface, by deep subcutaneous and/or supraperiosteal injection

适用患者

For adults 18 years of age or older, assessed as suitable by the treating practitioner, typically those presenting with midface volume deficit rather than a surface line to correct. It must not be used in those who tend to develop hypertrophic scars, have pigment disorders or a susceptibility to keloid formation, since treatment may trigger these complications. It must not be used in those known to be hypersensitive to hyaluronic acid, gram-positive bacterial proteins, lidocaine hydrochloride or amide-type local anaesthetics. It must not be used in pregnant or breast-feeding women, or in individuals younger than 18 years of age.

作用原理： Saypha Volume Plus Lidocaine ​

为什么选择在 Allpara 订购

Allpara 提供正品、经过验证的 SAYPHA 产品，来自经过严格审核的供应商，具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地，以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果，并提供专属售后支持，让您安心无忧。

常见问题